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Depression in adolescents if unrecognized, can interfere with every aspect of the 
individual’s life, increasing the risk for illness and interpersonal difficulties in the future. 
Therefore, it is imperative that significant levels of depressive symptoms be recognized, 
assessed, and treated. The usefulness and psychometric properties of new measures of depression 
are determined, in part, through comparison with existing measures. The current study 
investigated the concurrent validity of the Clinical Assessment of Depression (CAD; Bracken & 
Howell, 2004) with the Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, & 
Brown, 1996) for an adolescent population. The sample for this investigation consisted of 23 
adolescents (13-18 years) with a primary diagnosis of unipolar depression and 98 adolescents 
that did not have a clinical diagnosis. Correlation coefficients were large and statistically 
significant between the CAD and BDI-II, ranging from .97 to .66. The CAD was able to 
distinguish between clinical and non-referred groups on the basis of mean group scores. Using 
the BDI-II classification as the criterion, a contingency table was computed and a classification 
consistency of 82% for the total sample was found. Findings of the current study indicate that the 
CAD appears to have adequate validity to support its use with adolescents.   
 
 
 vi
 Review of the Literature 
 Depression is prevalent in the adolescent population and is often overlooked (Fritz, 1997; 
Peterson et al., 1993). It is important that depression be recognized, assessed, and treated in 
adolescents to reduce its impact on an individual’s life, increasing the risk of illness and 
interpersonal difficulties in the future. Self-report measures are often used for assessing 
depression in adolescents. It is important that the self-report measures used have evidence of 
adequate psychometric properties, including adequate validity. The present investigation will 
explore the concurrent validity of a newly developed measure of depression with an established 
measure. 
The next section will provide a review of literature relevant to the current investigation of 
the validity of the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004).  First, an 
overview of child and adolescent depression will be provided including incidence, 
symptomology, and diagnostic criteria.  Next, the assessment of depression in children and 
adolescents will be reviewed.  Last, the purpose of the present investigation will be presented. 
Depression in Adolescents 
Depression is a psychological disorder that is often overlooked among child and 
adolescent populations. According to Reynolds (1992), 8 to 18% of school-aged youth have 
experienced a clinical level of depression. Health care providers and family members of children 
and adolescents often view possible indicators of depression expressed by young people as 
typical mood swings and, as a result, the disorder remains under-diagnosed and untreated 
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(Evans, Velsor, & Schumacher, 2002; National Institute of Mental Health [NIMH], 2000).  
Children and adolescents often display classic symptoms such as low self-esteem, guilt, loss of 
interest in school activities, decreased school performance, and boredom, yet find these emotions 
difficult to identify or label in themselves (NIMH, 2000).   It is critical for the depressive 
symptoms of adolescents to be recognized, evaluated, and treated, as depression can increase the 
risk for illness and interpersonal difficulties in the future and affects almost every aspect of that 
individual’s life (Evans et al., 2002; Stanard, 2000).          
Research concerning childhood and adolescent depression has increased over the past 
two decades and a knowledge base regarding childhood depression has emerged.  Prevalence 
rates for major depression are comparable to that of adults, making depression a major health 
problem among this population.  The incidence of depression among youth in the United States 
ages 9-17 is estimated to be around 5%, with 1.5% to 4.7% being diagnosed with Major 
Depressive Disorder (Fritz, 1997; Pullen, Modrcin-McCarthy, & Graf, 2000; Stanard, 2000).   
The prevalence of depressive disorders differs in countries throughout the world.  Past 
research indicates percentages ranging from 11.7% of adolescents in East Germany to 40% of 
Bulgarian adolescents.  In the United States, Canada, and Britain, the prevalence was found to be 
around 10% and in Poland, the percentage was around 30 (Boyd, Gullone, Kostanski, Ollendick, 
& Shek, 2000).  While prevalence rates may vary across countries, depression appears to be a 
universal construct of significant concern in children and adolescents.  
Gender and depression.  When looking at the prevalence rates of depression by gender, 
an equal number of boys and girls suffer from depression prior to adolescence. The percentage of 
adolescent boys identified as experiencing a depressed mood is between 20 and 35% while for 
adolescent girls, the percentage rate is between 25 and 40 % (Peterson et al., 1993).  
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During adolescence, however, rates of unipolar depression (major depressive disorder, 
dysthymic disorder, or depressive disorder not otherwise specified) have been found to be higher 
for girls than for boys (Baron & Campbell, 1993; Herson & Ammerman, 2000; Marcotte, Fortin, 
Potvin, & Papillon, 2002; Rutter, Graham, Chadwick, & Yule, 1976). In a study comparing 
female and male mean scores on the Reynolds Adolescent Depression Scale (RADS) and the 
Beck Depression Inventory (BDI), Baron and Campbell (1993) examined whether females 
exhibit higher mean scores on discriminating items than males.  It was found that females do in 
fact have higher mean scores on these items. This supports the view that females 
characteristically report more depressive symptoms than males.   
Diagnostic criteria.  In determining a diagnosis of depression for adolescents, the criteria 
set forth by the Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision 
(DSM-IV-TR; American Psychiatric Association [APA], 2000) must be met.  The DSM-IV-TR 
consists of three diagnostic categories for unipolar depressive disorders.  Of importance to this 
investigation are the criteria for the unipolar types of depression: major depressive disorder, 
dysthymic disorder, and depressive disorder not otherwise specified. 
 As a severe form of depression, Major Depressive Disorder is characterized by one or 
more Major Depressive Episodes.  These episodes last at least two weeks and consist of 
depressed mood and loss of interest in most all activities. The individual must also suffer from at 
least four of the following symptoms: “changes in appetite or weight, sleep, and psychomotor 
activity; decreased energy; feelings of worthlessness or guilt; difficulty thinking, concentrating, 
or making decisions; or recurrent thoughts of death or suicidal ideation, plans or attempts” (APA, 
2000, p. 356).  
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 The second depressive diagnostic category is Dysthymic Disorder.  This form of 
depression consists of a less severe symptom pattern than major depression; however, the 
symptoms are chronic in that two or more symptoms are experienced for at least one year.  With 
children and adolescents, symptoms must last at least one year and may include: irritability, poor 
self-esteem, poor social skills, feelings of hopelessness, and impaired school performance (APA, 
2000). 
The third diagnostic category involving unipolar depression in the DSM-IV-TR is 
Depressive Disorder Not Otherwise Specified.  This form of depression includes depressive 
features consistent with that required to diagnose major depression or dysthymia, yet the 
symptom pattern does not meet the criteria for any other Depressive Disorders in severity, 
quantity, or duration. When there is inadequate or contradictory information, this form of 
depression may be used for diagnosis (APA, 2000). 
Adolescent symptoms.  While the same criteria are required for a diagnosis of Major 
Depressive Disorder in adolescents as in adults, the symptoms are commonly presented 
differently (Mash & Wolfe, 2002; Mellin & Beamish, 2002; Oster & Montgomery, 1994; 
Stanard, 2000).  Adolescents experiencing depressive disorders tend to exhibit more 
helplessness, fatigue, despair, lack of pleasure, suicidal thoughts, hypersomnia, and variations in 
weight than depressed adults (Reynolds, 1990; Wright-Strawderman, Lindsey, Navarrete, & 
Flippo, 1996).  Depressive disorders during adolescence also tend to be more episodic, with 
phases of depression, followed by phases of better functioning (Fritz, 1997; Mash & Wolfe, 
2002).  Impairments in academic performances and relationships with others is often noted in 
adolescents experiencing clinical levels of depression (Evans et al., 2002; Mellin & Beamish, 
2002).  Adolescent depression may also be expressed in ways that do not even resemble 
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depressive symptoms, such as behavior problems, family problems, substance abuse, or rebellion 
(Mellin & Beamish, 2002).  There are also gender differences in the expression of depressive 
symptoms.  Males tend to exhibit more irritability, work inhibition, sleep disturbance, and social 
withdrawal while females tend to exhibit more body image distortion, loss of appetite, sadness, 
dissatisfaction, and weight loss (Baron & Campbell, 1993). 
Assessment of Depression 
Use of self-report measures.  The diagnosis of depression is reached after a 
comprehensive assessment in which information about the individual’s symptoms and 
behavior/behavior patterns are obtained.  Recommended practices in diagnosis are to gain such 
information primarily through a multimodal assessment approach utilizing clinical/diagnostic 
interviews with the child/adolescent or their parent(s), documentation of the child’s/adolescent's 
behavior over time through use of behavior checklists, and self-report measures (Wright-
Strawderman et al., 1996). While all of these methods are important to use in a thorough 
assessment, self-report measures are frequently utilized to assess depression and are the focus for 
this investigation (Martin, 1988; Reynolds, 1990; Shinn, Walker, & Stoner, 2002; Stanard, 2000; 
Wright-Strawderman et.al., 1996). 
Self-report measures are frequently used in social-emotional assessment (Marcotte et al., 
2002; Stanard, 2000; Reynolds, 1990; Wright-Strawderman et al., 1996).  The utilization of such 
measures enables individuals to report their own internal thoughts, feelings, and emotions.  This 
allows for better first-hand information of an individual's internal experience of depression than 
what could be obtained from a third party’s observation of symptom patterns. 
Objective self-report measures are standardized instruments.  They require the 
completion of questions or items concerning an individual's own social or emotional behavior 
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and answers are compared to a population sample. It has been proposed by Martin (1988) that 
self-report measures must have four essential characteristics present before being considered for 
use: (a) adequate test-retest reliability, (b) standardized procedures, (c) normative data for 
comparison, and (d) adequate validity. 
Types of self report rating scales.  Self-report measures vary on the scope of the 
behaviors or symptomology covered.  There are some self-report measures available that deal 
with a broad range of symptomology; however, there are also measures available that focus only 
on depression symptomology.  Such standardized measures that assess adolescent depression 
include the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) and the 
Reynolds Adolescent Depression Scale (RADS; Reynolds, 1987).  While some measures are 
helpful as a screener to provide information regarding depressive symptoms, the RADS and the 
BDI-II provide a more systematic depth of coverage into depressive symptoms.  
The Beck Depression Inventory-II (BDI-II) was developed by Beck, Steer, and Brown 
(1996). The BDI-II replaced the original BDI (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and modernized the amended Beck Depression Inventory (BDI-IA; Beck, Rush, Shaw, & 
Emery, 1979). The BDI, and later the BDI-IA, have been the most widely used measures in 
assessing the severity of depression in psychiatric patients, as well as detecting depression in 
normal populations (Archer, Maruish, Imhof, & Piotrowski, 1991; Piotrowski & Keller, 1992; 
Piotrowski, Sherry, & Keller, 1985). The current edition of the BDI, the BDI-II, assesses the 
severity of depressive symptoms in adults and adolescents, ages 13 to 80.   It measures 
symptoms related to the cognitive, affective, behavioral, and somatic components of depression 
through responses to 21 items. A total score provides an estimate of the overall severity of 
depression.  
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In modernizing the amended Beck Depression Inventory, the revised BDI-II replaced 
items of Weight Loss, Body Image Change, Somatic Preoccupation, and Work Difficulty with 
Agitation, Worthlessness, Concentration Difficulty, and Loss of Energy. To allow for increases 
and decreases in appetite, two items were changed and many statements used in rating other 
symptoms were reworded. The BDI-II stands as a major revision of the BDI, more so than the 
BDI-IA, and was developed to be more consistent with DSM-IV criteria.  
The psychometric properties of the BDI-II are quite strong.  The BDI-II has good 
reliability and validity and has been shown to discriminate between individuals with depression 
and those without depression  (Beck, Steer, & Brown, 1996; Krefetz, Steer, Gulab, & Beck, 
2002; Plake & Impara, 2001). The BDI-II has shown to be a useful tool in assessing depression 
and it is widely used within the field of psychology (Camara, Nathan, & Puente, 2000; Plake & 
Impara, 2002; Wilcox, Field, Prodromidis, & Scafidi, 1998).  
As mentioned previously, Martin’s (1988) criteria described four essential characteristics 
that a self-report measure should possess in order to be considered a good self-report measure. 
The BDI-II has established test-retest reliability of .93 (Beck et al., 1996; Plake & Impara, 2001). 
Standardization procedures are utilized in the BDI-II in that test items are presented in a 
consistent manner, and the responses are compared to responses of other individuals.  The BDI-II 
provides normative data that allow a score to be compared to a larger group of individuals, and it 
has established validity (Beck, Steer, & Brown, 1996; Krefetz et al., 2002; Plake & Impara, 
2001).  Based on Martin’s criteria, the BDI-II is an established self-report measure that provides 
reliable, standardized, valid information to the professionals that utilize it. 
 The Clinical Assessment of Depression (CAD; Bracken & Howell, 2004) is an 
instrument that is under development by Psychological Assessment Resources (PAR). It was 
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developed to answer the question of whether or not depressive symptoms are consistent across 
the age range from childhood through adulthood. The existing published measures are designed 
either for adult or child populations. The CAD assesses depression among children, adolescents, 
and adults using a single form. Because the CAD is currently under development, there is limited 
information available.  However, preliminary information indicates that this measure has 
adequate test-retest reliability and validity (B. A. Bracken, personal communication, March 25, 
2004).   
Purpose of Present Investigation   
Self-report measures play an important role in the assessment of depression. Due to the 
internalizing nature of depression, an individual is more in tune to their own thoughts and 
feelings than what a third party can ascertain through observation (Merrell, 1999; Reynolds, 
1990; Stanard, 2000).  Since individuals are more credible sources of their own depressive 
symptoms, self-report measures are often used within the field of psychology. Further, the BDI-
II is one of the most frequently used measures in clinical psychology. In a survey conducted by 
Camara, Nathan, and Puente (2000), current uses of psychological assessment measures by 
clinical psychologists and neuropsychologists were investigated.  A rank-order list of the top 20 
tests used within the participants’ profession resulted in a BDI-II ranking of 10. Regarding the 
most often used personality measures, the BDI-II ranked second (Camara et al., 2000).  Thus, the 
BDI-II is a well-known and frequently used assessment tool for psychologists. 
In order to validate the usefulness and psychometric properties of new measures, existing 
measures are one criterion by which to judge new instruments.  According to the Standards for 
Educational and Psychological Testing (AERA, APA, & NCME, 1999), such investigations 
should be conducted prior to the instrument’s use in the field.  The purpose of this investigation 
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is to examine the concurrent validity of a measure under development, the Clinical Assessment 
of Depression (CAD), with an existing proven measure, the Beck Depression Inventory- Second 
Edition (BDI-II). The hypotheses for this investigation are as follows. 
1. The CAD total score and subscales will evidence strong concurrent validity with the 
BDI-II total score for the total sample. Concurrent validity will be evidenced by total 
scores yielding statistically significant, moderate to high correlations.   
2. The clinical group will evidence significantly higher mean scores on the CAD than 
the non-referred group and higher group mean scores on the BDI-II than the non-
referred group. 
In addition to the above hypotheses, the classification efficacy of the CAD was examined  
using the BDI-II as the criterion measure.
 
  
Method 
Participants 
The total sample consisted of 65 female and 56 male adolescents ages 13 to18. The mean 
age for the total sample was 15 years of age. The ethnicity of the total sample consisted of 111 
Caucasians, 9 African Americans, and 1 Other. The clinical sample comprised of 23 participants, 
13 females and 10 males, with a mean age of 15.0 years old. Among this group were 21 (91.3%) 
Caucasian and 2 (8.7%) African American participants. These participants had a clinician 
confirmed primary or secondary diagnosis of Major Depressive Disorder, Dysthymia, or 
Depressive Not Otherwise Specified (NOS), as based on DSM-IV-TR (APA, 2000) criteria.  
Participants for the clinical sample were allowed to have a dual diagnosis, as long as the 
additional diagnosis was not a diagnosis with a psychosis (e.g., Bi-Polar Disorder, 
Schizophrenia). The clinical participants were recruited through inpatient and outpatient 
facilities, as well as private practice clinicians’ offices. Comprising the clinical sample were 14 
adolescents with a primary diagnosis of Depressive Disorder NOS, 2 with Dysthymic Disorder, 1 
with Cyclothymic Disorder, 5 with Major Depression, and 1 with a secondary diagnosis of Major 
Depression. Of the clinical participants, 10 (44%) were not taking psychotropic medications.   
The non-referred sample consisted of 98 participants, 52 females and 46 males, recruited 
from a high school in south-central Kentucky. The mean age for the non-referred group was 15.4 
(SD=1.14) years old and this group included 92 (92%) Caucasians, 7 (7%) African Americans, 
and 1 (1%) Other. The participants were self-reported to have no existing diagnosis of Major 
Depression, Dysthymia, or Depressive NOS, as based on DSM-IV-TR (APA, 2000) criteria.  
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Instruments  
Beck Depression Inventory-Second Edition (BDI-II). The Beck Depression Inventory 
Second Edition (Beck, Steer, & Brown, 1996) is one of the most widely used self-report 
measures of depression (Camara et al., 2000; Plake & Impara, 2001; Wilcox et al.,1998). The 
high usage of the BDI-II is a continuation of the original BDI and BDI-IA. As a revision of the 
BDI-IA and original BDI, the BDI-II is a 21-item, self-report instrument that can be used with 
ages 13 to 80. The BDI-II can be used as an indicator of the presence and degree of depressive 
symptoms.     
 The BDI-II assesses symptoms of depression that correspond to criteria in the Diagnostic 
and Statistical Manual of Mental Disorders-Fourth Edition for diagnosing depressive disorders 
(APA, 2000).  The BDI-II takes approximately 5 to 10 minutes to complete, and can be 
administered orally if needed.  Items are rated on a 4-point scale, ranging from 0-3. In scoring 
the BDI-II, ratings are summed to derive a total score.  The maximum total score is 63. 
“Minimal” depression is represented by total scores of 0 to 13, “Mild” depression by total scores 
of 14 to 19, “Moderate” depression by total scores of 20 to 28, and total scores of 29 to 63 as 
“Severe” depression  (Beck, Steer, & Brown, 1996).  For this study, a cutoff score of 17 for 
depression was used, which is recommended by the manual. 
The psychometric properties of the BDI-II and its previous editions have been 
investigated for many years to support the use of the instrument with clinical and non-clinical 
populations. The BDI-II is the 1996 revision of the amended BDI-IA and the original BDI.   The 
BDI-II has not been independently studied as extensively as the previous editions.  However, the 
BDI-II adds to the 35 years of psychometric data collected on the BDI and BDI-IA. Therefore, 
psychometric data regarding the original BDI and/or BDI-IA may also be reported.   
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In reviewing 25 years of evaluation of the original BDI, Beck, Steer, and Garbin (1988), 
reported that the internal consistency of the BDI yielded coefficient alphas from .76 to .95, with 
a mean coefficient alpha of .86 for psychiatric populations. For nonpsychiatric samples, a mean 
alpha of .81 was determined, with the range being .73 to .92.  Strober, Green, and Carlson (1981) 
found a coefficient alpha estimate of internal reliability of .79 among 78 adolescent inpatients on 
the BDI.         
 A study by Beck, Steer, & Brown (1996) investigated the psychometric properties of the 
BDI-II.  A coefficient alpha internal consistency reliability of .92 was reported with an outpatient 
group, and .93 for the college students.  Of the 21 items on the BDI-II, corrected item-total 
correlations for the outpatient and college student samples were significant and ranged from 
correlations from .39 to .70 for the outpatient sample.  The college student sample correlations 
ranged from .27 to .74 (Beck, Steer, & Brown, 1996).   
In another investigation, a coefficient alpha of .89 for the BDI-II was obtained for college 
students, indicating a high internal consistency (Steer & Clark, 1997). Additionally, a study 
conducted by Beck, Steer, Ball, and Ranieri (1996) found internal consistencies of .91 for the 
BDI-II and a .89 for the BDI-IA, indicating that the internal consistency of the BDI-II is 
comparable to that of the BDI-IA.   
 Based on responses of a subsample of 26 outpatients, the BDI-II test-retest correlation 
was .93  (Beck et al., 1996). Strober et al. (1981) determined a test-retest correlation of .74 
among adolescents diagnosed with Major Depression, and .69 for adolescents with nonaffective 
diagnoses.   
 Convergent and discriminant validity of the BDI-II are evidenced through correlations 
with other psychological tests assessing similar constructs including:  the Hamilton Psychiatric 
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Rating Scale for Depression (HRSD), Beck Hopelessness Scale (BHS), Scale for Suicide 
Ideation (SSI), Beck Anxiety Inventory (BAI), and the Revised Hamilton Anxiety Rating Scale 
(HARS-R). The total test correlation between the BDI-II and the Beck Hopelessness Scale 
(BHS) was .68 and a correlation between the BDI-II and the Scale for Suicide Ideation (SSI) was 
.37.   The BHS and SSI evidence divergent validity.  The correlation between the BDI-II and the 
Beck Anxiety Inventory (BAI) was .60.  The BDI-II scores were most highly correlated with the 
Hamilton Rating Scale for Depression (HRSD) with a correlation of .71 (Beck, Steer, & Brown, 
1996: Krefetz et al., 2002; Plake & Impara, 2001).  Thus the BDI-II evidences convergent and 
divergent validity.  
Krefetz et al. (2002) investigated the convergent validity of the BDI-II with the Reynolds 
Adolescent Depression Scale (RADS; Reynolds, 1987). The findings indicated similar 
psychometric properties between the BDI-II and RADS with coefficient alpha internal 
consistency reliability greater than .90. These internal consistencies of the BDI-II and RADS 
were found to be excellent for clinical purposes according to Cicchetti’s (1994) guidelines. 
Inpatient adolescents diagnosed with Major Depressive Disorder indicated more severe 
depression than those who were not diagnosed with Major Depressive Disorder. Additionally, 
results support BDI-II convergent validity for assessing depression in adolescent inpatients 
through self-report. A correlation between the BDI-II and the RADS was found to be positive 
and strong (r =  .84).  
The review of the BDI-II provides support for its usefulness in assessing adolescent 
depression. As an established measure, the BDI-II has strong psychometric properties. The BDI-
II appears to be good and plausible measure in indicating the presence and degree of depressive 
symptoms. 
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  Clinical Assessment of Depression (CAD).  The Clinical Assessment of Depression 
(CAD) is currently in development by Psychological Assessment Resources.  It is a 50-item 
scale that takes approximately 10 minutes to complete. The CAD has four subscales, which are: 
Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue. The 
age range for this measure is 9 to 79 years.  The CAD assesses depressive symptomology in six 
diagnostic categories: Negative Affect, Irritability/Agitation, Interest in Pleasure, Positive Affect, 
Energy, and Cognitive Efficiency.  Items in these categories were developed using wording and 
content appropriate for all ages.  
In scoring the CAD, item scores are computed into an overall T-score. The CAD does not 
specify a specific cutoff score; rather, clinicians are suggested to use a cutoff T-score that they 
are comfortable in using. However, qualitative risk categories of T-scores are indicated as the 
following: 50 = Normal range, 60-69 = Mild Clinical Risk range, 70-79 = Significant Clinical 
Risk range, >79 = Very Significant Clinical Risk range (B. Bracken, personal communication, 
March 23, 2004).  For this study, a cutoff T-score of 60 was used.  
Because the CAD is currently under development, there are limited psychometric data 
available at this time. Among age, race, and gender, the CAD reliability analyses have varied 
slightly with the Total Scale score range of alpha coefficients being .96 to .98 across subsamples. 
The reliability of the subscales on the CAD vary slightly by subsamples: Depressed Mood = .95 
to .97, Anxiety/Worry = .82 to .90, Diminished Interest = .79 to .92, Cognitive and Physical 
Fatigue = .79 to .91. The CAD Total Scale score test-retest reliability has been found to be .81 to 
.87.  For the CAD subscales, strong confirmatory factor analysis support has been found. 
Concurrent validity was evidenced in correlations between the CAD and the BDI-II total scores 
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with ages 8-18 evidencing a correlation of r = .71 and individuals above 18 years evidencing a 
correlation of  r = .87  (B. Bracken, personal communication, March 23, 2004).    
Procedure 
The Human Subjects Review Board of Western Kentucky University reviewed and 
approved the procedures of this study (see Appendix A). The subjects for the clinical group were 
recruited through inpatient and outpatient facilities, as well as private practice clinicians.  Once 
permission was obtained to solicit participants from these treatment providers, the treatment 
providers were given packets and directions for distributing forms (see Appendix B) to 
parents/guardians. Treatment providers were also given local fast food restaurant coupons (not 
exceeding a $2.00 value) to distribute to each participant upon completion of a packet. 
 Treatment providers distributed the packets to the parent/guardian. Each packet 
contained a letter including the description of the study and an invitation to participate, a parent 
consent form, a release of information form, an adolescent assent form, an instruction sheet, and 
the CAD and BDI-II depression measures (see Appendix B). To expedite data collection, the 
conductor of this study combined data collection with another researcher; therefore, the 
Reynolds Adolescent Depression Scale (RADS), was an additional measure included in the 
packets. The RADS was not used for the current study.  
The instruction sheet found within each packet asked the parent/guardian to complete the 
consent form and the release of information form. The adolescents were asked to complete the 
assent form and the three depression measures. Upon completion of the three depression 
measures and the consent and assent forms, participants were asked to place and seal the 
measures in one envelope and the consent and assent forms in the separate envelope provided.   
 
 16
The parent/guardian and/or participant were instructed to return both packets to their 
treatment provider. The conductor of this study retrieved the packets from the providers.  The 
conductor of this study then asked the treatment providers to complete the Clinician’s Record 
Form after a signed release form was obtained from the parent/guardian (see Appendix B).   
 Subjects comprising the non-referred group were solicited from a local high school in 
south-central Kentucky.  For data collection at the high school, an introductory letter and consent 
form (see Appendix C) was sent home with randomly selected 9th, 10th, 11th, and 12th grade 
classrooms.  Students who returned forms to school received a local fast food restaurant coupon 
that did not exceed a value of $2.00.  A coupon was given for returning the consent form whether 
or not consent was granted. The students for whom parental consent was obtained were asked to 
sign an assent form and complete three measures during school hours. An appropriate time for 
completion of questionnaires, which was approximately 25 minutes, was determined between the 
researcher and the students’ teachers.  A coding system was used so that a student could be 
identified in the event of significant responses indicating depression or suicidal ideation. 
Parent/guardians were notified by the researcher when significant scores for depression were 
found in this group. Names were kept separate from all forms, with no names appearing on the 
forms.  
 
   
Results 
The current study had two primary purposes: (a) to examine the strength of the 
relationship between the CAD and the BDI-II, and (b) to determine whether group 
differences existed between the clinical and non-referred group on the CAD and BDI- II. 
Additionally, the hit rate or classification efficacy of the CAD was examined using the BDI-II as 
the criterion measure. Table 1 provides the means and standard deviations of the raw scores for 
each measure broken down by group and gender.  
 To examine the relationship between the BDI-II and CAD, correlation coefficients were 
computed between the total score on the BDI-II and total score and each subscale of the CAD 
(Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue). 
Using the Bonferroni approach to control for Type I error across the 15 correlations, a p value of 
less than .003 was established for significance. The results of the correlational analyses are 
presented in Table 2. All correlations were statistically significant and large using Cohen’s 
(1988) effect sizes. The results indicate strong concurrent validity between the total score on the 
BDI-II and the total score on the CAD, as well as between the BDI-II and each subscale of the 
CAD.  
To determine whether group differences existed between the clinical and non-referred 
groups, independent sample t tests were computed to see if each measure (BDI and CAD) 
evidenced mean score differences between the two groups (clinical and non-referred). 
Levene’s Test for the Equality of Variances was computed due to the unequal number of 
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Table 1 
Sample Descriptive Statistics for the Raw Scores on the BDI-IIa and the CADb  
 
 
  BDI-II     CAD 
Sample  N M SD SEM  N M SD SEM  
 
Non-referred 
     Male  52   9.80   8.50 1.27  47  97.34  29.81 4.35 
     Female  46 15.22 12.59 1.76  52 107.12  29.29 4.06 
     Total  98 12.68 11.15 1.14  99 102.47  29.80 2.99 
Clinical 
     Male  10 12.90   9.20 2.91  10 106.40  26.07  8.25  
     Female  13 25.15 13.67 3.79  13 138.77  27.33  7.58 
     Total   23 19.83 13.23 2.76  23 124.70  30.90  6.44 
Total Sample 
     Male  62 11.35 16.43 2.20  57 101.87 29.18 3.86 
     Female  59  20.19 19.27 2.40  65 122.95  31.4 3.90 
     Total            121 16.26 18.94 1.72  122 106.66  31.12 2.82  
 
Note.  Clinical sample consisted of individuals diagnosed with Major Depressive Disorder, 
Dysthymia, or Depressive Disorder, NOS. 
aBeck Depression Inventory – Second Edition.  bClinical Assessment of Depression. 
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 Table 2            
Correlations of BDI-IIa total score with CADSb total score and Scales                                     
 
Subscale 
 
1      2   3   4 
 
  5   6 
1. CAD Total Score - .97* .93* .90* .86* .77* 
2. CAD, Depressed Mood - - .86* .84* .76* .75* 
3. CAD, Anxiety/Worry  - - - .78* .78* .74* 
4. CAD, Diminished Interest - - - - .77* .64* 
5. CAD, Cognitive & Physical Fatigue - - - - - .66* 
6. BDI-II Total Score - - - - - - 
                                                                     
aBeck Depression Inventory – Second Edition.  bClinical Assessment of Depression.   
 
* p < .004 
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participants in the groups. All significance levels were found to be above .05, indicating no 
violation of the assumption of homogeniety of variance. Therefore the t tests were interpretable. 
The t tests were significant, t (117) = -2.66,  p =.009 for the BDI-II, and t (120) = -3.2,  p =.002 
for the CAD. The results support the hypothesis that the clinical group will evidence higher mean 
scores on each of the two measures than the non-referred group. Participants in the clinical group 
displayed higher mean scores on both measures than participants in the non-referred group. 
 Classification efficacy of the CAD was examined using the BDI-II as the criterion 
measure.  According to Bracken (personal communication, March 23, 2004), a cutoff T-score of 
60 is recommended for distinguishing between depressed and non-depressed individuals. Using 
the BDI-II cutoff score of 17 and comparing CAD categories of depression (T > 60) and non-
depressed to actual BDI-II findings, a 2 X 2 contingency table was computed (Table 3) for the 
total sample.  The distribution of the score classification between the BDI-II cutoff score and the 
CAD cutoff score were found to be significant, Χ2 = 44.72, (p < .000), indicating cell proportions 
found are not a chance occurrence.  Cell proportions indicated that 82% of the total sample was 
correctly identified by the CAD when using the BDI-II as its criterion measure (see Table 3).  
 Additional contingency tables were computed in order to understand the classification 
efficacy of the CAD and BDI-II using group membership (clinical and non-referred) as the 
criterion. Table 4 shows a contingency table for the CAD and group membership. The hit rate for 
the CAD was found to be 68%. There were 25% false positives and 7% false negatives. The 
distribution within the contingency table was significant (Χ2 = 44.72,  p < .000) indicating that 
this was not a chance occurrence. Table 5 shows a contingency table for the BDI-II and group 
membership.  The hit rate for the BDI-II was found to be 68%. There were 24% false positives  
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Table 3 
Total Sample Classification Table between BDI-IIa and CADb Diagnosis of Depression 
______________________________________________________________________________ 
      
               CAD Classification 
 BDI-II Classification Non-depressed Depressed    Total 
           
     Non-depressed   
 
56% 
(n=68) 
10% 
(n=12) 
66% 
(n=80) 
      Depressed 8% 
(n=10) 
26% 
(n=32) 
34% 
(n=42) 
      Total 64% 
(n=78) 
36% 
(n=44) 
100% 
(n=121) 
______________________________________________________________________________ 
Note. Χ2 = 44.72,  p < .000. 
aBeck Depression Inventory – Second Edition; depression classification based on raw score > 17.   
bClinical Assessment of Depression; depression classification based on T-scores > 60.  
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Table 4 
Classification Table between CADa Diagnosis of Depression and Group Membershipb 
 
        CAD Classification 
            __________________________________ 
 
 Group Membership Non-Significant Depressed Total 
      
 Non-Referred 
 
57% 
(n=69) 
 
25% 
(n=30) 
 
81% 
(n=99) 
      Clinical 7.4% 
(n=9) 
11.5% 
(n=14) 
19% 
(n=23) 
      Total 64% 
(n=78) 
36% 
(n=44) 
100% 
(n=122) 
___________________________________________________________________________________________________________________ 
Note. Χ2 = 44.72,  p < .000. 
aClinical Assessment of Depression; depression classification based on T-score > 60.  
bNon-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23 
individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder, 
Dysthymia, or Depressive Disorder, NOS.  
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Table 5 
Classification Table between BDI-IIa Diagnosis of Depression and Group Membershipb 
 
            BDI-II Classification 
                     ___________________________ 
 
 Group Membership Non-Significant Depressed Total 
      Non-Referred 66% 
(n=81) 
15% 
(n=18) 
81% 
(n=99) 
      Clinical 12.3% 
(n=15) 
6.6% 
(n=8) 
19% 
(n=23) 
      Total 66% 
(n=80) 
34% 
(n=42) 
100% 
(n=122) 
______________________________________________________________________________ 
Note. Χ2 = 44.72,  p < .000. 
aBeck Depression Inventory, Second Edition; depression classification based on raw score > 16.  
bNon-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23 
individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder, 
Dysthymia, or Depressive Disorder, NOS. 
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 and 8% false negatives. The distribution within the contingency table was significant (Χ2 = 
44.72,  p < .000) indicating that this distribution was not a chance occurrence. 
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Discussion 
The purpose of the current study was to determine the strength of the relationship 
between the BDI-II and the CAD. High correlations between the two measures were expected. 
The second purpose was to examine whether the CAD could discriminate between the clinical 
and non-referred participant groups. The clinical group participants were expected to have 
significantly higher total scores on the CAD than the non-referred participants. Additionally, the 
hit rate or classification efficacy between the CAD and BDI-II was examined.  
 In determining the strength of the relationship between the CAD and BDI-II, some 
noteworthy results were found. Significant, strong correlation coefficients were found between 
the total BDI-II score and the total score and each subscale of the CAD (Depressed Mood, 
Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue). The strongest 
correlation (.97) was between the CAD total score and the CAD Depressed Mood subscale and 
the weakest correlation (.66) was between the BDI-II total score and the CAD Cognitive and 
Physical Fatigue scale. The correlations obtained account for 75%-94% of the variance on the 
two measures. The findings support the hypothesis that the CAD will evidence strong concurrent 
validity with the BDI-II. 
 The second purpose was to establish whether the CAD can discriminate between clinical 
and non-referred populations on the basis of group mean scores.  Independent samples t tests 
were computed to determine if there were mean differences for the two groups (clinical and non-
referred) on the two measures (CAD and BDI-II).  The t test for the BDI-II indicated that the two 
populations can be discriminated on the basis of group mean scores.  The t test for the CAD was 
also significant indicating that the clinical group could be distinguished from the non-referred 
group on the basis of mean group scores on this measure.  For both measures, higher mean 
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scores were found for the clinical groups than for the non-referred group. These findings support 
the hypothesis that the clinical group will evidence higher mean scores than the non-referred 
group.   
The third purpose was to examine the hit rate or classification efficacy, using the BDI-II 
as the criterion measure. A Chi square procedure was used and a 2 X 2 contingency table was 
computed. From the analyses, 10% of the sample was categorized as false positives on the CAD. 
Individuals classified as depressed on the CAD were non-depressed on the BDI-II (the criterion). 
False negatives were also determined. Individuals classified as non-depressed on the CAD were 
found to be depressed on the BDI-II. Eight percent of the total sample (n = 10) fell within the 
false negative category. Considered as the more conservative, false positives are more preferred. 
In examining the classification efficacy, a hit rate for the total sample was determined as 
high at 82%. However, there were 10% false positives and 8% false negatives. In looking at 
group membership, a hit rate of 68% was found for the CAD and BDI-II.  With the CAD, there 
were 25% false positives and 7% false negatives found. On the BDI-II, there were 24% false 
positives found and 8% false negatives found. In the event that the two measures are not 
perfectly correlated, it would be expected to find some classification differences between the 
measures.  
There are also three other possible explanations for the classification differences found. 
One explanation could be the small sample size of clinical group participants (n=23) when 
compared to the non-referred group participants (n=98). A higher hit rate found with the non-
referred group may be because of the larger sample size. A second explanation is that more 
clinical group participants were from outpatient facilities than from inpatient facilities.  As such, 
it would appear that the clinical sample consisted of less severely depressed individuals. A third 
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explanation could be the uncertainty of the clinical participants status on the continuum of 
depression. The researcher was unaware of how long each participant had been diagnosed with 
depression and had been receiving treatment.     
Limitations  
  Before findings of the current study can be interpreted and generalized, limitations of the 
study need to be considered. The small sample size, limited geographic area, and small 
percentage of ethnicities represented among the participants of the clinical and non-referred 
groups may have limited the amount of information gathered and the generalizability of the data 
obtained. Also, the recruitment of clinical participants from both inpatient and outpatient 
facilities may explain some of the classification discrepancies between the measures (hit rate).   
 For the current study, it is difficult to know if any events occurred prior to completion of 
the two measures that may have impacted the responses of the participants and threatened 
internal validity (e.g., relationship difficulties, school stress).  An additional threat to internal 
validity is that the non-referred group was self-reported to have no existing diagnosis of 
depression. It is possible that some participants of this group did in fact have a diagnosis of 
depression. Based on the ratings on the two measures (BDI-II and CAD), 21 individuals in the 
non-referred group had clinically significant levels of depression.   
 A threat to external validity of the study is noted, in that the clinical sample relied on 
treatment providers to recruit clinical participants to ensure confidentiality. Individuals 
diagnosed with depression and not seeking treatment were not included in this study.  Another 
threat to external validity is that the clinical sample was not homogeneous.  Some participants 
had secondary diagnoses and one participant had depression as the secondary diagnosis. In 
addition, the clinical sample represented all diagnoses of depression and not just one particular 
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diagnosis such as Major Depression only or Dysthymia only. A more homogeneous sample may 
have provided different or more consistent findings.  
Other factors impacting the external validity of the study include the extent and method 
of treatment the clinical participants were receiving and whether the participants were currently 
taking any medications.  A final threat to external validity is that the data for this study were 
collected in one geographic location (south-central Kentucky). Although the clinical and non-
referred sample was relatively balanced for gender and representative of the ethnicity of the 
region, 7% minority, generalizability to other geographic regions may not be valid.  
Implications 
 Practical implications.  The major implication of the current study is that psychometric 
evidence has been established and provided for the CAD’s use as a measure for assessing 
depression in adolescents. The hit rate or classification efficacy when using the BDI-II as a 
criterion measure was established as high. The current study has also expanded the knowledge 
base of available adolescent depression measures.  While depression measures are limited for 
children and adolescent populations, it is important that additional measures be established, in 
addition to the CAD and BDI-II.  With prevalence rates of childhood depression on the rise, and 
the high need for professionals to utilize depression measures (Camara et al., 2000), it is 
imperative that valid and reliable measures be established and made accessible.  Measures that 
can adequately identify and diagnosis depressive symptoms will increase the likelihood of 
accurate treatment.  
Further research.  In regard to future research, the psychometric properties of the CAD 
warrant further investigation.  Additional studies addressing differing age groups, different 
clinical groups (outpatient versus inpatient), and more homogeneous diagnoses may help to 
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further clarify the usefulness of the CAD.  Future research should also investigate the subscales 
of the CAD with other established measures that measure wider ranges of symptomology, 
including depression, such as rating scales that assess both internalizing and externalizing 
behaviors.  In addition, future studies should expand sample size and the geographic area to 
enhance the generalizablity of findings.  Evidence of validity should also be obtained through 
factor analytic procedures to substantiate the subscale structure of the CAD.
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WESTERN KENTUCKY UNIVERSITY  
Human Subjects Review Board  
Office of Sponsored Programs  
104 Foundation Building  
270-745-4652; Fax 270-745-4211  
E-mail: Phillip.Myers@Wku.Edu  
In future correspondence please refer to HS03-077, April 3, 2003 
Shanna Bowers  
1500 Crossbreeze Ct.  
Bowling Green, KY 42104  
 
Dear Shanna: 
  
Your research project, "Concurrent Validity of Adolescent Depression Measures," was reviewed 
by the HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable; 
and that (2) research procedures are consistent with a sound research design and do not expose 
the subjects to unnecessary risk. Reviewers determined that: (1) benefits to subjects are 
considered along with the importance of the topic and that outcomes are reasonable; (2) selection 
of subjects is equitable; and (3) the purposes of the research and the research setting is amenable 
to subjects' welfare and producing desired outcomes; that indications of coercion or prejudice are 
absent, and that participation is clearly voluntary.  
1. In addition, the IRB found that: (1) signed informed consent will be obtained from all 
subjects. (2) Provision is made for collecting, using and storing data in a manner that protects 
the safety and privacy of the subjects and the confidentiality of the data. (3) Appropriate 
safeguards are included to protect the rights and welfare of the subjects. (4) Any ad or flyer 
used to recruit participants must be reviewed by the HSRB before used.  
a. Your research therefore meets the criteria of Full Board Review and is Approved.  
2. Please note that the institution is not responsible for any actions regarding this protocol before 
approval. If you expand the project at a later date to use other instruments please re-apply. 
Copies of your request for human subjects review, your application, and this approval, are 
maintained in the Office of Sponsored Programs at the above address. Please report any changes 
to this approved protocol to this office. A Continuing Review protocol will be sent to you in the 
future to determine the status of the project.  
Sincerely,  
Phillip E. Myers, Ph.D.  
Director, OSP and  
Human Protections Administrator  
 
cc: Human Subjects File HS03-077  
cc: Shanna Bowers  
cc: Dr. Elizabeth Jones 
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Dear Parent/Guardian, 
 
Your child is invited to participate in a study looking at the usefulness of 3 measures of social and 
emotional well-being.  This study is being conducted by Shanna Bowers, Brooke Wootton and Dr. 
Elizabeth Jones of Western Kentucky University in cooperation with your child’s clinician.  The 
results of the study will be used to determine how well these 3 instruments measure social and 
emotional well-being in adolescents.   
 
In addition, the data from this study will be used to evaluate a new instrument that measures  social 
and emotional well-being.  Such data can provide information about the new instruments’ usefulness 
and ability to measure what it sets out to measure.  If you agree to allow your child’s responses to be 
used in this evaluation process, there is a separate consent form included in this packet that requires 
your signature.  This form will be returned to the test publisher.   
 
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires 
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.  It 
will take approximately 25 minutes to complete and this may be done before or after your child’s 
therapy sessions. You will also be asked to complete a release of information form to allow your 
child’s therapist to release diagnosis, medication, and family history information. This information 
will only be used by the researchers to insure that research requirements are met. Your child’s name 
will not appear on this form.  For your child’s participation in this study he or she will receive a local 
fast food restaurant coupon that will not exceed a $2.00 value. 
  
Your consent and your child’s participation are completely voluntary.  At any time withdrawal from 
the study is possible.  If you do not consent for your child to participate, it will have no negative 
outcomes for you or your child and will not affect the relationship with the clinician.  There are no 
physical risks involved in filling out the questionnaires.  However, answering the items on the 
questionnaires may cause your child to feel some emotional discomfort, due to the nature of the 
questions asked about your child’s behavior. All information collected in this study will be kept 
strictly confidential and will be accessible only to project staff.  However, all packets will be coded 
to allow for identification only if an individual's responses indicate a threat to self or others on the 
questionnaires.  Researchers must by law report this information to your child’s clinician and you 
will be immediately informed.  
 
The procedures in this study have been reviewed and approved by the Western Kentucky University 
Human Subjects Review Board.  If you have questions about the study you may contact Dr. Elizabeth 
Jones by phone at (270) 745-4414.  We hope that both you and your child agree to take part in our study.  
To indicate your consent for participation please complete and sign the attached form, have your child 
complete the questionnaires, and return the packet to your child’s clinician. 
  
Sincerely, 
 
 
Elizabeth L. Jones   Shanna Bowers Brooke Wootton 
Associate Professor of Psychology   School Psychology Graduate Students 
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Participation Consent Form 
 
Child’s Age ____ Child’s Gender  __ M   __F    Child’s Race/Ethnicity________ 
 
 
I have read the information provided concerning this study.  I give consent for my child to 
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones 
of Western Kentucky University.  I understand that I may withdraw from the study at any time 
without penalty. 
 
 
_____ I DO give consent for my child to participate in this study. 
 
 
_____ I DO NOT give consent for my child to participate in this study. 
 
 
Parent/Guardian Signature ______________________________ Date __________ 
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PARENT/GUARDIAN CONSENT FORM 
Research Participation in a Behavioral Study 
 
General Information and Purpose 
My child:____________________ has been asked to participate in a research study 
being conducted by PAR, Inc., a developer and publisher of educational and behavioral 
assessment tools.  The purpose of the study is to evaluate a new test designed to 
identify behavioral problems in adolescents.  I have been asked to participate in this 
study because I am the parent of a child (ages 2 to 18 years); if my child is between 8 
and 18-years-old, he or she has also been asked to participate. 
 
What is involved in my child’s participation? 
If I agree (and give consent for my child) to participate in this study, my child will 
complete one or more questionnaires that ask about my child’s academic, social, and 
personal behaviors.  Children questionnaires take from 15 to 30 minutes to complete. 
 
Risks 
There is no physical risk involved in filling out the questionnaires.  Answering the 
questions on the questionnaires may cause my child to feel some emotional discomfort, 
due to the nature of the questions asked about my child’s behavior. 
 
Benefits 
The results of this study may be of benefit in the future to children with behavioral 
problems and the professionals who evaluate and treat them. There is no immediate 
benefit to my child for their participation, however they may benefit in the event 
that they indicate suicide or harm to others. If such indicators are present, they 
will be identified and I will be identified immediately.  
 
Confidentiality 
My child’s answers on the questionnaires are strictly confidential and 
anonymous.  I will not be asked to put my child’s name on the questionnaires.  
Only the primary researchers or their designees will have access to my child’s 
confidential survey responses.  However, the packets will be coded to allow for 
identification only if my child’s responses indicate suicide or harm to others.  By 
law researchers must report this information to you immediately.  
 
Right to Withdraw or Decline to Participate 
My child’s participation in this study is completely voluntary.  He/she may choose not to 
participate, or to withdraw from participation at any time without penalty. 
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I attest that I have read and understand all of the above pertaining to my child’s 
participation in this study, and that all of my questions about the study have been 
answered to my satisfaction.  I hereby give my informed consent for my child to 
participate in this research study. 
 
____________________________  ____________________________     
Parent’s Name (please print)             Parent’s Signature                                         Date 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If you have any questions regarding this research study or participation in it, please call Michelle Owens or Dr. Mario Rodriguez (Project Director) at 1-866-PAR-
DATA or 1-800-331-TEST.  PAR, Inc./16204 N. Florida Avenue, Lutz FL 33549/Tel (813)968-3003/Fax (813)968-4684 
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Release of Information 
 
CONCURRENT VALIDITY STUDY OF ADOLESCENT DEPRESSION MEASURES 
 
 
 
(1) TO:_______________________________  (2) DATE:__________________ 
 
       _______________________________ 
 
       _______________________________ 
 
  
(3) RE:___________________________ 
        Name 
             ___________________________ 
        Address 
 
Authorization is hereby granted to release to Western Kentucky University (WKU) researchers: 
Dr. Elizabeth Jones, Shanna Bowers, and Brooke Wootton, and Psychological Assessment 
Resources (PAR) researchers such information relative to service rendered.   
 
              
             (4) ___________________________ 
        Signature of Parent 
 
              ___________________________ 
        Address 
 
              ___________________________ 
       
 
 
 
(5) ____________________________         ___________________________ 
      Witness          Date 
 
 
Information particularly requested is listed below: 
Your Childs: Age   
Gender 
  Race  
  Primary DSM-IV Diagnosis 
  List of Current Medications 
  Family History of DSM-IV Diagnosis  
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As mentioned before, the purpose of this study is to use self-report measures to identify social 
and emotional well-being in adolescents.  To ensure that the participants of this study meet 
diagnosis criteria, it is necessary to obtain diagnosis information from a clinician.   
 
Attached is a release form that must be completed so that your child’s therapist can release 
diagnosis and medication information to the researchers. 
 
• Fill in the name of your child’s therapist at #1 
 
• Put today’s date at #2 
 
• Put your child’s name at #3 
 
• Sign your name, provide address and date at #4 
 
• Have a witness (someone over 18 years of age) sign at #5 
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Participation Assent Form 
 
I have read and understand the information provided about this study.  I give assent to participate 
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western 
Kentucky University.  I understand that I may withdraw from this study at any time without 
penalty. 
 
I, ________________________, understand that my parent/guardian has given permission for 
me to participate in a study concerning social and emotional well-being, under the direction of 
Western Kentucky University. 
 
My participation in this project is completely voluntary, and I understand that I may stop my 
participation in this study at any time.  I am aware that I am encouraged to answer all of the 
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items.   If 
I choose not to participate, it will not affect my treatment in any way. 
 
Signature _________________________  Date____________ 
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Bracken Survey 
Project 
 
 
Clinician Record Form
Date: ________________Clinician Name:_____________________________________
 
 
Please provide the following information for the individual participant being rated/tested. 
Age:______
 
 
ID No.: _____________________
Gender: ______ Race/Ethnicity: ____________
Primary DSM-IV Diagnosis(es): _____________________________________________________
Estimated Date of Dx: ______________ 
        Psychiatrist 
        Primary care physician 
        Other: _______________ 
Diagnosis made by:         Psychologist 
       Pediatrician 
      School Personnel1) ________________ 
Current?
Yes No 
Yes No 
Yes No 
Estimated Date of Dx: ______ Secondary 
DSM-IV 
Diagnoses: Estimated Date of Dx:_______ 2) ________________
Estimated Date of Dx: _______ 3) ________________
Current Psychotropic Medications: 1) ___________________________________________
2) ___________________________________________
3) ___________________________________________
  No    YesDoes either parent or any sibling carry a DSM-IV diagnosis(es)? 
If yes, indicate biological relative(s) and respective diagnosis(es):
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Dear Parent/Guardian, 
 
Your child is invited to participate in a study looking at the usefulness of 3 measures of social 
and emotional well-being used with adolescents.  This study is being conducted by Shanna 
Bowers, Brooke Wootton and Dr. Elizabeth Jones of Western Kentucky University.  The results 
of the study will be used to determine how well these 3 instruments measure social and 
emotional well-being in adolescents.   
 
In addition, the results of this study will be used to evaluate a new instrument that measures 
social and emotional well-being. Such data can provide information about the new instrument’s 
usefulness and ability to measure what it sets out to measure.  If you agree to allow your child’s 
responses to be used in this evaluation process, there is a separate consent form included in this 
packet that requires your signature.  This form will be returned to the test publisher. 
 
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires 
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.  
It will take approximately 25 minutes to complete the three questionnaires.  
For your child’s participation in this study he or she will receive a local fast food restaurant 
coupon that will not exceed a $2.00 value.  
 
Your consent and your child’s participation are completely voluntary.  At any time withdrawal 
from the study is possible.  If you do not consent for your child to participate, it will have no 
negative outcomes for you or your child.  There are no physical risks involved in filling out the 
questionnaires.  However, answering the items on the questionnaires may cause your child to feel 
some emotional discomfort, due to the nature of the questions asked about your child’s behavior.  
All information collected in this study will be kept strictly confidential and will be accessible 
only to the project staff. However, all packets will be coded to allow for identification only if an 
individual's responses indicate a threat to self or others on the questionnaires.  Researchers must 
by law report this information to you immediately.  
 
The procedures in this study have been reviewed and approved by the Western Kentucky 
University Human Subjects Review Board.  If you have questions about the study you may 
contact Dr. Elizabeth Jones by phone at (270) 745-4414.  We hope that both you and your child 
agree to take part in our study.  To indicate your consent for participation please complete and 
sign the attached form. 
 
Sincerely, 
 
 
Elizabeth L. Jones   Shanna Bowers Brooke Wootton 
Associate Professor of Psychology   School Psychology Graduate Students
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Participation Consent Form 
 
Child’s Age ____ Child’s Gender  __ M   __F     Child’s Race/Ethnicity________  
 
I have read the information provided concerning this study.  I give consent for my child to 
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones 
of Western Kentucky University.  I understand that I may withdraw from the study at any time 
without penalty. 
 
 
_____ I DO give consent for my child to participate in this study. 
 
 
_____ I DO NOT give consent for my child to participate in this study. 
 
 
Parent/Guardian Signature_______________________________ Date __________ 
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Participation Assent Form 
 
I have read and understand the information provided about this study.  I give assent to participate 
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western 
Kentucky University.  I understand that I may withdraw from this study at any time without 
penalty. 
 
I, ________________________, understand that my parent/guardian has given permission for 
me to participate in a study concerning social and emotional well-being, under the direction of 
Western Kentucky University. 
 
My participation in this project is completely voluntary, and I understand that I may stop my 
participation in this study at any time.  I am aware that I am encouraged to answer all of the 
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items. 
Whether or not I choose to participate, I will not be affected in any way. 
 
Signature _________________________  Date____________ 
 
 
